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Summary
The mtDNA variation of 50 Spanish and 4 Cuban fam-
ilies affected by nonsyndromic sensorineural deafness
due to the A1555G mutation in the 12S rRNA gene was
studied by high-resolution RFLP analysis and sequencing
of the control region. Phylogenetic analyses of haplo-
types and detailed survey of population controls revealed
that the A1555G mutation can be attributed to 30
independent mutational events among the 50 Spanish
families and that it occurs on mtDNA haplogroups that
are common in all European populations. This indicates
that the relatively high detection rate of this mutation
in Spain is not due to sampling biases or to a single
major founder event. Moreover, the distribution of these
mutational events on different haplogroups is compat-
ible with a random occurrence of the A1555G mutation
and tends to support the conclusion that mtDNA back-
grounds do not play a significant role in the expression
of the mutation. Overall, these findings appear to in-
dicate that the rare detection of this mutation in other
populations is most likely due to inadequacy in patient
ascertainment and molecular screening. This probable
lack of identification of the A1555Gmutation in subjects
affected by sensorineural hearing loss implies that their
maternally related relatives are not benefiting from pre-
symptomatic detection and information concerning their
increased risk of ototoxicity due to aminoglycoside
treatments.
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Introduction
The A1555G mutation in the 12S rRNA gene has been
the first mtDNA mutation associated with nonsyn-
dromic sensorineural deafness (MIM 580000 and MIM
561000) (Fischel-Ghodsian et al. 1993; Hutchin 1999;
Prezant et al. 1993). This mutation was initially de-
scribed mainly in subjects who became deaf after ami-
noglycoside exposure, thus indicating that, because of
this mutation, patients’ mitochondrial ribosomes had be-
come targets of aminoglycosides, in a manner similar to
that seen in the evolutionarily related bacterial ribo-
somes (for a review, see Fischel-Ghodsian 1998, 1999).
However, more recently this mutation also has been
found in numerous deaf subjects who apparently were
never exposed to aminoglycosides (El-Schahawi et al.
1997; Estivill et al. 1998; Sarduy et al. 1998). The
A1555G mutation has been reported in affected families
of different ethnic origin (Hutchin et al. 1993; Prezant
et al. 1993; Matthijs et al. 1996; Fischel-Ghodsian et al.
1997; Gardner et al. 1997; Pandya et al. 1997), and
haplotype and phylogenetic studies also have shown that
affected families do not generally share the A1555G mu-
tation by descent but that it has arisen independently
numerous times (Hutchin and Cortopassi 1997; Abe et
al. 1998; Estivill et al. 1998). In addition, although initial
studies had suggested that only a small proportion of
familial sensorineural hearing loss was due to the
A1555G mutation, several studies have now proposed
that this mutation could be rather common (Fischel-
Ghodsian et al. 1997; Usami et al. 1997; Estivill et al.
1998; Sarduy et al. 1998; Hutchin 1999). In particular,
two independent studies of Spanish families detected
high incidence of the A1555G mutation among pedi-
grees affected with sensorineural hearing loss—in 19 of
70 pedigrees in one study (Estivill et al. 1998) and in
32 of 134 in another study (I. del Castillo and F. Moreno,
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unpublished data). The identification of such a large
number of families in Spain, relative to the few detected
in other European populations (Casano et al. 1998), has
led us to investigate the haplotype and phylogenetic re-
lationships of the Spanish A1555G mtDNA samples, to
determine whether this higher frequency is due to a par-
ticular history/origin of the mutation in Spanish affected
families and/or to some particular features of mtDNA
variation in the general Spanish population. A hypo-
thetical role of mtDNA haplogroups in disease expres-
sion, as well as the possible existence of putative founder
effects, were also investigated.
Subjects and Methods
Subjects
mtDNA variation was analyzed in 54 subjects (50
from Spain and 4 from Cuba) affected by nonsyndromic
sensorineural deafness who previously had been found
to be positive for the presence of the A1555G mutation
in the 12S rRNA gene. Appropriate informed consent
was obtained from these subjects. All of these individuals
were from families that, according to interview of family
members, were maternally unrelated at least within the
preceding four generations. The maternal origins of the
Spanish subjects represented a wide range of regions,
including Old and New Castile, Estremadura, Catalonia,
Andalusia, the Basque Country, and the Balearic Islands.
Of the 50 Spanish subjects, 2 had been described pre-
viously by El-Schahawi et al. (1997), 19 by Estivill et
al. (1998), and 5 by Sarduy et al. (1998). Genomic DNA
was extracted from buffy coats by standard procedures.
The molecular screening for the mutation A1555G was
performed as described by Estivill et al. (1998) or in
Sarduy et al. (1998), and the mutation was always found
to be homoplasmic, except in one patient, as reported
by El-Schahawi et al. (1997).
High-Resolution RFLP Analysis and Phylogenetic
Analysis of RFLP Haplotypes
To determine high-resolution RFLP haplotypes, the
entire mtDNA of each of the 54 subjects was amplified
in nine overlapping fragments, by PCR and the primer
pairs described by Torroni et al. (1997). Each of the nine
PCR segments was then digested with 14 restriction
endonucleases (AluI, AvaII, BamHI, DdeI, HaeII,
HaeIII, HhaI, HincII, HinfI, HpaI, MspI, MboI, RsaI,
and TaqI). In addition, all subjects were screened for the
presence/absence of the BstOI site at nucleotide position
13704, the AccI sites at nucleotide positions 14465 and
15254, the BfaI site at nucleotide position 4914, the
NlaIII sites at nucleotide positions 4216 and 4577, and
the MseI site at nucleotide position 14766. The ArG
sequence polymorphism at nucleotide position 12308 in
the tRNALeu gene was also tested, by a mismatched
primer that generates a HinfI site when the A12308G
mutation is present (Torroni et al. 1996). Restriction
fragments were resolved as described elsewhere (Torroni
et al. 1997).
Phylogenetic relationships between RFLP haplotypes
of the patients and those found in 237 European control
subjects were inferred by parsimony analysis. The den-
drograms were rooted on the basis of the mid-rooting
point. Maximum parsimony (MP) trees were generated
through random addition of sequences, by the tree-bi-
section-and-reconnection algorithm (PAUP 3.1.1; Swof-
ford 1993).
Sequencing of the mtDNA Control Region (CR)
Sequencing of the mtDNA CR between nucleotide po-
sitions 16003 and 16490 was performed both for all
mtDNA samples that, on the basis of RFLP analysis,
had proved to be members of haplogroup H and for
some of the non-H mtDNA samples, including those
which shared an identical RFLP haplotype. The CR se-
quence between nucleotide positions 40 and 460 also
was determined for a few of these mtDNA samples. Se-
quencing was performed as previously described by Tor-
roni et al. (1998).
Results
RFLP Haplotype Analysis of mtDNA with the A1555G
Mutation
Table 1 shows data on high-resolution RFLP haplo-
types detected in the 50 Spanish patients (samples 1–50)
and 4 Cuban patients (samples 51–54). Twenty-four
RFLP haplotypes (haplotypes 1–15 and 17–25) were
found among the Spanish patients, and two (haplotypes
16 and 26) were found among the Cuban patients. Over-
all, these haplotypes were defined by 56 polymorphic
restriction sites.
All the observed haplotypes were characterized by spe-
cific combinations of mutations (underlined in table 1)
that previous studies had shown to define major mono-
phyletic mtDNA clusters or haplogroups (Torroni et al.
1994, 1996, 1998; Chen et al. 1995; Macaulay et al.
1999). Thirty-eight (76.0%) of the Spanish mtDNA
samples harbored the RFLP motif 7025 AluI,14766
MseI, which is characteristic of the most common Eu-
ropean-specific haplogroup, haplogroup H (Torroni et
al. 1996, 1998; Macaulay et al. 1999). Although hap-
logroup H represented the majority of Spanish mtDNA
samples, most of the other haplogroups specific to Eur-
opeans also were observed. Indeed, haplogroups V, T,
and I were each represented by one subject (2.0%). Hap-
logroup-J and -U mtDNA samples were each observed
in two subjects (4.0%), and haplogroup K was repre-
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sented by three individuals (6.0%). The two remaining
Spanish mtDNA samples (4.0%) were found to harbor
RFLP motives that are characteristic of the African-spe-
cific haplogroups L1 and L2 (Chen et al. 1995). The
presence of African-specific mtDNA in Spain has been
described elsewhere (Coˆrte-Real et al. 1996) and prob-
ably reflects the arrival of north Africans during the Mes-
olithic (8,000 B.C.) and/or during the recent Arabic rule,
which started ∼800 A.D. (Arnaiz-Villena et al. 1997).
The mtDNA samples from the four Cuban patients be-
longed to two haplogroups. One of these mtDNA sam-
ples was a member of the African haplogroup L1, and
the remaining three showed an identical haplotype (hap-
lotype 16) belonging to haplogroup U.
The 38 Spanish haplogroup-H mtDNA samples were
encompassed by 12 different RFLP haplotypes (RFLP
haplotypes 1–12) (table 1). Haplotypes 2 and 5 were
very common, being represented by 13 and 9 of the
Spanish families, respectively. Other haplogroup-H hap-
lotypes also were observed in more than one family.
These included haplotype 8 (four families) and haplo-
types 3, 4, and 7 (two families each). All other Spanish
RFLP haplotypes were found in a single family.
The phylogenetic relationships between the RFLP hap-
lotypes of the 54 patients and the haplotypes previously
described in 237 European controls are illustrated in
figure 1. The distribution of the 54 mtDNA samples
harboring the A1555G mutation in the parsimony tree
appears to indicate that, at least as a first approximation,
the A1555G mutation is due to 24 independent muta-
tional events among the 50 Spanish subjects and two
mutational events among the 4 Cuban patients.
Sequence Analysis of the mtDNA CR
To better define the relationships between the mtDNA
samples harboring the A1555G mutation and the num-
ber of events that have generated this mutation, we se-
quenced the portion of the CR between nucleotide po-
sitions 16003 and 16490 that includes the entire first
hypervariable segment (HVS-I). This sequence analysis
was performed for all haplogroup-H mtDNA samples
and for a few other mtDNA samples, including all of
those which shared an identical haplotype (haplotype 16
observed in three Cubans).
This analysis revealed heterogeneity among the 12
Spanish mtDNA samples harboring haplotype 2 and in-
dicated that they were subdivided into six subgroups
(2.1–2.6) (table 1). Similarly, the two mtDNA samples
harboring haplotype 4 showed different CR sequences
(4.1 and 4.2). In contrast, identical CR sequences were
observed among the Spanish families harboring haplo-
types 3, 5, 7, and 8. Also, the three Cubans with hap-
lotype 16 showed an identical CR.
To further study the origin of the A1555G mutation
in the families harboring haplotype 5, we sequenced the
CR between nucleotide positions 40 and 460, which
includes the entire second hypervariable segment (HVS-
II) of two haplotype-5 mtDNA samples (samples 14 and
21). These were both defined by the motif 93G-95C-
263G and by the presence of an additional C in the
stretch of C’s located between nucleotide positions 311
and 315. In addition, sample 21 was found to be het-
eroplasmic for the presence of an extra C in the hyper-
variable stretch of C’s between nucleotide positions 303
and 309.
Haplogroup Distribution of mtDNA from Spanish
Patients and Spanish Controls
Table 2 illustrates the haplogroup distribution of the
mtDNA observed in the 50 Spanish subjects harboring
the A1555G mutation. To determine whether this dis-
tribution corresponded to that of the general Spanish
population, 182 control mtDNA samples from different
regions of Spain were screened for the marker mutations
that distinguish European haplogroups (Torroni et al.
1996; Macaulay et al. 1999).
This comparison showed that haplogroup H encom-
passed ∼76% of the patients’ mtDNA samples but only
∼45% of the Spanish control mtDNA samples, a dif-
ference that is highly significant (two-sided Fisher’s exact
test; ). In contrast, observed frequencies ofP = .0001
other haplogroups in patients were all compatible with
a random distribution of the A1555G mutation.
Discussion
Multiple Origins of the A1555G Mutation in Spain
High-resolution RFLP analysis of 50 Spanish subjects
affected by sensorineural deafness has shown that the
A1555G mutation is associated with 24 RFLP haplo-
types and that those haplotypes are members of a wide
range of haplogroups (H–K, T–V, L1, and L2). The pres-
ence of the mutation on different haplogroups confirms
that it has occurred multiple times in the Spanish pop-
ulation (Estivill et al. 1998). However, RFLP analysis
also allows a quantitation of the number of independent
occurrences of the A1555G mutation. A previous study
has estimated that, with the set of restriction enzymes
used in this analysis, one restriction-site change (other
than 16517 HaeIII, which is hypervariable) from a foun-
der haplotype requires 24,420 years, on average (Torroni
et al. 1998). Thus, unless the possibility is accepted that
the A1555G mutation has been transmitted by descent
for tens of thousands of years to mtDNA that, in the
meantime, has diverged into different haplotypes, we
have to believe that each of the 24 different haplotypes,
including the 12 haplotypes belonging to haplogroup H,
represents at least one independent occurrence of the
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Figure 1 Phylogenetic tree of RFLP haplotypes from patients with the deafness mutation A1555G. This mid-rooting-point maximum-
parsimony tree includes 24 RFLP haplotypes (1–15 and 17–25) observed in 50 apparently unrelated Spanish patients (blackened circles), 2
RFLP haplotypes (16 and 26) observed in 4 Cuban patients (blackened squares), and the haplotypes previously described in 237 unrelated
European controls. The capital letters H–M and T–X indicate haplogroups, and the numbers associated with the lowercase letters indicate the
sites for restriction enzymes that define the specific haplogroups. The restriction enzymes are designated by single-letter code as follows: a =
AluI; b = AvaII; c = DdeI; e = HaeIII; f = HhaI; g = HinfI; h = HpaI; k = RsaI; j = MboI; i = MspI; l = TaqI; m = BamHI; n = HaeII; q = NlaIII;
r = BfaI; s = AccI; t = BstoI; u = MseI. The horizontal branch lengths are proportional to the number of mutational events that separate the
haplotypes, with the exception of sites 10394c, 16303k, 16310k, and 16517e. In the parsimony analysis, these sites were assigned half the
weight (i.e., 1) assigned to all other sites (i.e., 2). This tree is 430 steps in length and has consistency and retention indices of .652 and .896,
respectively.
A1555G mutation. This scenario gets support from the
observation that most of these haplotypes also have been
previously detected in population controls from either
Spain or other European countries (Torroni et al. 1994,
1996). For instance, haplogroup-H haplotypes 1–4 and
10 all have been observed in a sample of only 25 hap-
logroup-H mtDNA samples from the Basque population
(Torroni et al. 1998). Two notable exceptions are rep-
resented by haplotypes 5 and 8, which encompass 18%
and 8%, respectively, of the Spanish subjects with the
A1555G mutation. The former haplotype is character-
ized by the presence of the sites HaeIII at nucleotide
position 93 and RsaI at nucleotide position 8255, and
the latter haplotype is characterized by the absence of
the HaeIII site at nucleotide position 8838 (table 1).
Neither of these haplotypes had been observed previ-
ously in European populations. To obtain further infor-
mation on the distribution of haplotypes 5 and 8, we
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Table 2
Haplogroup Distribution of mtDNA from Spanish Subjects with the Deafness Mutation A1555G and from
Spanish Controls
GROUP
FREQUENCY OF mtDNA, FROM SPANISH SUBJECTS, IN HAPLOGROUP
(%)
Ha I J K T U V W X L M Other
Deaf individuals ( )n = 50 76.0 2.0 4.0 6.0 2.0 4.0 2.0 ) ) 4.0 ) )
Controls ( )n = 182 45.1 1.1 4.4 3.3 9.9 14.3 5.5 1.1 1.6 3.3 .5 9.9
a The difference between patients and controls is highly significant (two-sided Fisher’s exact test; ).P = .0001
screened 82 haplogroup-H control mtDNA samples
from Spain, to determine their distinguishing RFLP mu-
tations; none of the controls was found to harbor these
haplotypes.
Haplotype 2 is considered to be the founder haplotype
of haplogroup H, is the most common haplotype in Eu-
ropean populations, and encompasses more than one-
third of haplogroup-H mtDNA samples (Torroni et al.
1998). Therefore, it was not unexpected that 13 of the
38 haplogroup-H mtDNA samples with the A1555G
mutation were associated with this haplotype. In addi-
tion, because of the high frequency of haplotype 2 in
the general population, it is also likely that the A1555G
mutation has occurred more than once, on different hap-
lotype-2 mtDNA samples. Thus, to obtain a better es-
timation of the number of mutational events that had
produced the A1555G mutation in our Spanish sample,
we performed CR sequencing of all haplogroup-H
mtDNA samples.
This analysis revealed that six different CR motifs
(2.1–2.6) were associated with RFLP haplotype 2. With
the exception of CR motif 2.2, all of these had been
reported previously in European populations. Haplotype
2.3 is identical to the reference sequence and is the most
common haplogroup-H CR motif. Haplotypes 2.1 and
2.6 have been described in several populations, including
some from Spain (Coˆrte-Real et al. 1996; Salas et al.
1998); haplotype 2.4 has been described in the British
(Piercy et al. 1993) and Italians (Torroni A, unpublished
data); and haplotype 2.5 has been reported in Germans
(Richards et al. 1996). Also, the two haplotype-4
mtDNA samples were found to harbor different CR se-
quences (4.1 and 4.2 in table 1), both of which had been
reported previously in numerous European populations.
Thus, it appears that the A1555G mutation has occurred
at least six times on haplotype-2 mtDNA and twice on
haplotype-4 mtDNA and that, overall, this mutation was
originated by at least 30 independent mutational events
in the 50 Spanish families.
Origin of the A1555G Mutation in Cuban Subjects
One of the Cuban mtDNA samples was found to be-
long to the African haplogroup L2 and obviously rep-
resents one mutational event of the A1555G mutation.
In contrast, the other three Cuban mtDNA samples were
found to harbor the same RFLP haplotype (haplotype
16). These three subjects were not maternally related in
the preceding four generations, but they were all from
the same area (the town of Guines). Sequencing of the
CR confirmed the homogeneity of the three samples and
showed that all of them harbored the CR motif 16163-
16172-16219-16311. This motif is characteristic of a
particular subset of subhaplogroup U6 (Macaulay et al.
1999), and it is restricted to the Canary Islands (Rando
et al. 1998). Thus it appears that haplotype 16 observed
in the Cubans most likely arrived from the Canary Is-
lands. This origin is further supported by the fact that
the town of Guines historically has been a settlement
place for immigrants from the Canary Islands.
Founder Events of the A1555G Mutation
The analysis of the haplogroup distribution of the
Spanish mtDNA samples harboring the A1555G mu-
tation has shown a strong excess of haplogroup-H
mtDNA. A priori, two alternative genetic phenomena
could explain this observation. One is that haplogroup
H—or a specific subset of this haplogroup—plays a role
in deafness expression and increases the penetrance of
the A1555G mutation. For instance, this hypothetical
increase of penetrance could be due to the presence of
a predisposing mutation that exacerbates the effect of
the A1555G mutation. In this scenario, the excess of
haplogroup H—or of specific subsets of H—would be
caused by a sampling bias due to the fact that affected
individuals or families with a more extreme phenotype
are more likely to attract the attention of clinicians and
thus are more likely to be sampled. A role of mtDNA
background in disease expression has been postulated
previously for Leber hereditary optic neuropathy
(LHON). Among patients with LHON, a strong excess
of haplogroup-J mtDNA has been observed, and it has
been proposed that a number of mutations specific to
this haplogroup increase the penetrance of the LHON
mutations 11778 and 14484 (Howell et al. 1995; Brown
et al. 1997; Hofmann et al. 1997; Lamminen et al. 1997;
Torroni et al. 1997). Alternatively, the excess of hap-
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logroup-H mtDNA samples harboring the A1555G mu-
tation could be due to founder events. In other words,
the A1555G mutation observed in different families
would not be due to independent mutational events but
would have been transmitted by descent to families that
are indeed maternally related.
The combined RFLP-CR analysis permits us to dis-
criminate between these two alternative scenarios. Eigh-
teen of the 30 mutational events observed in the 50
Spanish families have occurred on haplogroup-H
mtDNA samples. This proportion is not significantly dif-
ferent from the random occurrence expectation of 13.5
of 30 mutations (Yates’s ; ) when the fact2x = 2.1 P 1 .10
that haplogroup H represents ∼45% of the general Span-
ish population is taken into account. This finding indi-
cates that independent mutational events on a haplo-
group-H background are not more likely to be identified
by clinicians because of increased penetrance. Therefore,
the possibility of a role of haplogroup-H background in
disease expression appears to be unlikely. In contrast,
the possibility that the increased frequency of haplo-
group H among Spanish patients is due to founder events
appears to be substantiated by two pieces of evidence.
First, since haplogroup H is by far the most common
haplogroup in Spain, it is most likely that random foun-
der events would involve this haplogroup. Second, the
combined RFLP-CR haplotype analysis revealed that
several haplotypes—2.1, 2.3, 3.1, 5.1, 7.1, and 8.1—are
shared by different families. Among these haplotypes,
2.1 (three individuals), 5.1 (nine individuals), and 8.1
(four individuals) were not observed among our Spanish
controls and have not been reported previously in ex-
tensive population studies conducted in Spain and other
European countries. Thus, it is beyond doubt that af-
fected families with haplotypes 2.1, 5.1, and 8.1 have
acquired the A1555G mutation by descent from com-
mon maternal ancestors. Since our families have been
unrelated for the preceding four generations, these com-
mon female ancestors in whom the mutational event
occurred are not very recent. This raises the possibility
that the degree of selection against the A1555G mutation
is much lower than that of most other pathological
mtDNA mutations—and that this mutation can be trans-
mitted for numerous generations, at least in some par-
ticular demographic situations. However, a confirmation
of this would require accurate and extensive genealogical
studies that, thus far, we have not been able to conduct.
Similarly, it is also most likely that the three Cuban fam-
ilies harboring haplotype 16.1 all have acquired the dis-
ease mutation from the same woman. Extensive gene-
alogical studies of the Cuban families and identification
of affected families living in the Canary Islands could
indicate whether this mutation has occurred in the Ca-
nary Islands, or alternatively, in a Cuban woman of Can-
arian ancestry and could define the age of this particular
mutational event.
In conclusion, here we have reported the most exten-
sive study yet of mtDNA variation in individuals affected
by sensorineural deafness and harboring the A1555G
mutation in the 12S RNA gene. This mutation can be
attributed to30 independent mutational events among
50 affected Spanish families. This indicates that the rel-
atively high detection rate of this mutation in Spain (Es-
tivill et al. 1998; Sarduy et al. 1998) is not due to either
sampling biases or a single major founder event. More-
over, the distribution of these mutational events on dif-
ferent haplogroups is compatible with a random occur-
rence of the A1555G mutation and supports the general
conclusion that mtDNA backgrounds do not play a sig-
nificant role in the expression of the mutation. As would
be expected when numerous families affected by a rel-
atively uncommon disease are sampled, some founder
events also were detected. The fact that all of these fam-
ilies were not related in the preceding four generations
raises the possibility that the A1555G mutation and the
associated phenotype are not under a strong selective
pressure and can be transmitted for numerous
generations.
Overall, these results raise a major question. If the
A1555G in Spain is due to numerous independent mu-
tational events occurring randomly on all mtDNA back-
grounds, and if mtDNA backgrounds do not affect its
penetrance, why has this mutation been so rarely de-
tected/reported in other European populations? One the-
oretical possibility is that the Spanish population is much
more exposed to exacerbating environmental factors, in-
cluding aminoglycoside treatment, than are other Eu-
ropean populations. During the 1950s and ’60s, peni-
cillin associated with streptomycin was commonly given
to Spanish patients with tonsillitis. Also, streptomycin
was used in the treatment of tuberculosis, which was
observed to have a high prevalence in Spain after the
civil war. However, there is no evidence of any other
major difference—in diet, living conditions, or medical
treatments—between Spain and most other western Eu-
ropean countries. In addition, even if we were to hy-
pothesize that our conclusion about the lack of a role
of mtDNA background in disease expression was wrong,
no major differences would be expected between the
Spanish and other Europeans, since haplogroup H is by
far the most common mtDNA haplogroup and has sim-
ilar frequencies in all western European populations.
Thus, there are only two explanations left. One expla-
nation is that in the Spanish there is, relative to other
European populations, a higher incidence of unidentified
nuclear genetic variants that facilitate the expression of
the A1555G mutation. However, this explanation also
appears to be unlikely. For instance, the large body of
genetic studies summarized by Cavalli-Sforza et al.
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(1994) does not reveal major genetic differences in the
gene pool of the general Spanish population, relative to
the gene pools of other western European countries. Al-
ternatively, the rare detection of the A1555G mutation
in other European populations could be due to inade-
quacy in patient identification and/or in pedigree anal-
ysis and to a bias, on the part of most research groups
that investigate the genetic basis of deafness, toward the
ascertainment of congenital cases.
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